NeoPharm CO., LTD. Stock Price

KOSDAQ:A092730 Community·₩312.7b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

A092730 Share Price Performance

₩0

-11810.00 (-100.00%)

₩0

-11810.00 (-100.00%)

₩0

Tue, 24 Feb 26

Share Pricen/a

A092730 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Flawless balance sheet, undervalued and pays a dividend.

0 Risks

4 Rewards

View Full Analysis

NeoPharm CO., LTD. Key Details

Last Reported Earnings

Sep 30, 2025

Next Reporting Earnings

n/a

: 1.78k
: 66.19%
: 21.41%
: 0%

View Full Analysis

About A092730

Founded: 2000
Employees: 178
CEO: Byeong-Deog Park
WebsiteView website: www.neopharm.co.kr

NeoPharm CO., LTD. engages in the manufacturing and sale of skin care products in South Korea. The company provides Atopalm, a non-steroid product for sensitive and dry skin; skin dermo-cosmetic products under the Real Barrier brand name; sensitive, dry, oily, or trouble-prone skin care products under the ZEROID brand; body moisturizers under the Derma-B brand name; sport care products under the MISSION ATHELETCARE brand; and dermArtlogy, a 1:1 consulting cosmetic brand. NeoPharm CO., LTD. was founded in 2000 and is headquartered in Daejeon, South Korea.